Abstract
Efforts are underway to develop a technique which will accelerate the acceptance of skin grafts and hasten the establishment of functional circulation in the treatment of burns. A proposed method involves the use of acidic fibroblast growth factor (FGF-1) which is delivered through a porous fibrin matrix on the angiogenic, epithelial, and fibroblastic response of the skin graft. In vivo testing was conducted using a partial thickness defect model in 12 New Zealand rabbits with two time periods. A relatively constant rate of FGF-1 release was observed. The FGF-1 exhibited greater angiogenesis, increased cellular infiltration, and overall healing rate over the non-FGF-1 adhesives.
Original language | English |
---|---|
Pages | 27 |
Number of pages | 1 |
Publication status | Published - 1996 |
Externally published | Yes |
Event | Proceedings of the 1996 5th World Biomaterials Congress. Part 2 (of 2) - Toronto, Can Duration: 29 May 1996 → 2 Jun 1996 |
Conference
Conference | Proceedings of the 1996 5th World Biomaterials Congress. Part 2 (of 2) |
---|---|
City | Toronto, Can |
Period | 29/05/96 → 2/06/96 |